Additionally, among the metabolic syndrome population, community population, and in non-alcoholic fatty liver disease patients, hepcidin concentrations were found to be an independent predictor of the presence of carotid plaques [18, 23, 24]. This evidence concerns the gene HAMP and metabolic syndrome.